Trials / Recruiting
RecruitingNCT07226934
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
Feasibility and Preliminary Efficacy of GPT-QPL: An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 20 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to evaluate the feasibility and preliminary efficacy of an artificial intelligence (AI)-generated personalized question prompt list (a list of suggested questions to ask during outpatient appointments) for patients with hematologic cancers. The intervention will involve tailoring a standardized prompt to patients' individual characteristics and concerns. This prompt will then be used to ask Washington University's (WashU) HIPAA compliant ChatGPT to generate personalized question lists for outpatient appointments. Analyses will assess the impact of personalized QPLs on patients' question-asking behavior; communicative self-efficacy; and self-reported amount and satisfaction with information obtained about their disease and its treatment. Sub-analyses will explore patterns in questions generated by WashU ChatGPT. Patients will also provide feedback pertaining to the perceived helpfulness and ease-of-use of WashU-ChatGPT-generated question lists, as well as their attitudes and intentions regarding use of AI chatbots and whether they would engage in pre-appointment AI-assisted question brainstorming independently in the future.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | GPT-QPL | A research team member will generate a QPL that is personalized to the patient's demographics (from EHR screening and Baseline Demographic Survey) and concerns (from Distress Thermometer Problem Checklist and Interview). |
Timeline
- Start date
- 2025-12-26
- Primary completion
- 2026-04-30
- Completion
- 2026-04-30
- First posted
- 2025-11-12
- Last updated
- 2026-03-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07226934. Inclusion in this directory is not an endorsement.